Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
The net profit margin is 0.00% as of the fiscal period ended Tuesday, June 30, 2026.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): 0.00%.
NET PROFIT MARGIN
0.00%
NET PROFIT MARGIN AVG TTM
0.00%
NET PROFIT MARGIN AVG 3Y
0.00%
NET PROFIT MARGIN AVG 5Y
0.00%
NET PROFIT MARGIN AVG 10Y
0.00%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 627 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Eledon Pharmaceuticals, Inc.
Market Cap
$191.04M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$192.33M
Net Profit Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$180.08M
Net Profit Margin
-6559.27%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$202.37M
Net Profit Margin
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$178.89M
Net Profit Margin
-8.95%
TTM Avg
-22.31%
3Y Avg
-22.43%
5Y Avg
-24.59%
Market Cap
$173.70M
Net Profit Margin
-435.83%
TTM Avg
-267.41%
3Y Avg
-1429.19%
5Y Avg
-1238.68%
Market Cap
$173.59M
Net Profit Margin
0.00%
TTM Avg
-2904.41%
3Y Avg
-1452.20%
5Y Avg
-968.14%
Market Cap
$172.45M
Net Profit Margin
-170.10%
TTM Avg
-145.13%
3Y Avg
-100.04%
5Y Avg
-83.24%
Market Cap
$211.50M
Net Profit Margin
-850.13%
TTM Avg
-398.77%
3Y Avg
-257.91%
5Y Avg
-325.14%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Eledon Pharmaceuticals, Inc. (ELDN) | $191.04M | 0.00% | 0.00% | 0.00% | 0.00% |
| AN2 Therapeutics, Inc. (ANTX)vs › | $192.33M | 0.00% | 0.00% | 0.00% | 0.00% |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.08M | -6559.27% | 0.00% | 0.00% | 0.00% |
| Electra Therapeutics Inc. (ETRA)vs › | $202.37M | N/A | N/A | N/A | N/A |
| Journey Medical Corporation (DERM)vs › | $178.89M | -8.95% | -22.31% | -22.43% | -24.59% |
| Cue Biopharma, Inc. (CUE)vs › | $173.70M | -435.83% | -267.41% | -1429.19% | -1238.68% |
| Compass Therapeutics, Inc. (CMPX)vs › | $173.59M | 0.00% | -2904.41% | -1452.20% | -968.14% |
| MediWound Ltd. (MDWD)vs › | $172.45M | -170.10% | -145.13% | -100.04% | -83.24% |
| Alector, Inc. (ALEC)vs › | $211.50M | -850.13% | -398.77% | -257.91% | -325.14% |
| Precision BioSciences, Inc. (DTIL)vs › | $171.13M | -117.04% | -61.51% | -173.42% | -194.84% |
Operating Margin
0.0%
Net Profit Margin
0.0%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | 0.00% |
| 2026-03-31 | 0.00% |
| 2025-12-31 | 0.00% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.00% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-09-30 | 0.00% |
| 2018-06-30 | 0.00% |
| 2018-03-31 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-09-30 | 0.00% |
| 2017-06-30 | 0.00% |
| 2017-03-31 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-09-30 | 0.00% |
| 2016-06-30 | 0.00% |
| 2016-03-31 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-09-30 | 0.00% |
| 2015-06-30 | 0.00% |
| 2015-03-31 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-09-30 | 0.00% |
| 2014-06-30 | 0.00% |
| 2014-03-31 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-09-30 | 0.00% |
